These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 12945718

  • 1. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
    Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS.
    Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
    [Abstract] [Full Text] [Related]

  • 2. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S.
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [Abstract] [Full Text] [Related]

  • 3. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
    Brunner HI, Silverman ED, Bombardier C, Feldman BM.
    Arthritis Rheum; 2003 Jun 15; 49(3):335-41. PubMed ID: 12794788
    [Abstract] [Full Text] [Related]

  • 4. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun 15; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 5. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.
    Arthritis Rheum; 2008 Feb 15; 58(2):556-62. PubMed ID: 18240232
    [Abstract] [Full Text] [Related]

  • 6. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA, GLADEL.
    Ann Rheum Dis; 2017 Dec 15; 76(12):2071-2074. PubMed ID: 28939626
    [Abstract] [Full Text] [Related]

  • 7. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov 15; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

  • 8. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb 15; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
    Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM.
    Arthritis Rheum; 2002 Feb 15; 46(2):436-44. PubMed ID: 11840446
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C.
    Lupus; 2004 Feb 15; 13(12):900-5. PubMed ID: 15645743
    [Abstract] [Full Text] [Related]

  • 11. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R.
    Rheumatology (Oxford); 2008 Feb 15; 47(2):183-7. PubMed ID: 18160418
    [Abstract] [Full Text] [Related]

  • 12. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
    Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, Fortin PR, Gladman DD, Fessler BJ, Alarcón GS, Bruce IN, Dooley MA, Steinsson K, Khamashta MA, Ramsey-Goldman R, Manzi S, Sturfelt GK, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Aranow C, Mackay M, Ruiz-Irastorza G, Kalunian KC, Lim SS, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Theriault C, Thompson K, Farewell V.
    Arthritis Rheum; 2013 Nov 15; 65(11):2887-97. PubMed ID: 24166793
    [Abstract] [Full Text] [Related]

  • 13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Nov 15; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 14. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA, Abaza NM, Hammam N, Mohamed AAA, El-Gazzar II, Eissa AH.
    Lupus; 2018 Jun 15; 27(7):1081-1087. PubMed ID: 29460701
    [Abstract] [Full Text] [Related]

  • 15. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J, Handwerger B.
    Rheumatology (Oxford); 2004 Dec 15; 43(12):1555-60. PubMed ID: 15342927
    [Abstract] [Full Text] [Related]

  • 16. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 15; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 17. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.
    Hill DD, Eudy AM, Egger PJ, Fu Q, Petri MA.
    Lupus Sci Med; 2021 Apr 15; 8(1):. PubMed ID: 33832976
    [Abstract] [Full Text] [Related]

  • 18. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb 15; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

  • 19. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.
    J Rheumatol; 1999 Feb 15; 26(2):490-7. PubMed ID: 9972993
    [Abstract] [Full Text] [Related]

  • 20. Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE.
    Gao CC, Liu SY, Wu ZZ, Li TF, Gao GM, Liu ZS, Zheng ZH.
    Lupus; 2016 Oct 15; 25(11):1224-9. PubMed ID: 26921268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.